ATLAS / Macro Radar / Reporting / MIRA

MIRA PHARMACEUTICALS, INC. (MIRA) reporting calendar

MIRA PHARMACEUTICALS, INC. files periodic reports with the SEC as MIRA on Nasdaq. Atlas tracks 12 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 5 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
12

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open MIRA market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001493152-26-023005
10-K31 Dec 202531 Mar 202690 days0001493152-26-014001
10-Q30 Sep 202513 Nov 202544 days0001493152-25-022112
10-Q30 Jun 202514 Aug 202545 days0001641172-25-024077
10-Q31 Mar 202514 May 202544 days0001641172-25-010301
10-K31 Dec 202428 Mar 202587 days0001641172-25-001183
10-Q30 Sep 202412 Nov 202443 days0001493152-24-044747
10-Q30 Jun 202413 Aug 202444 days0001493152-24-031612
10-Q31 Mar 202413 May 202443 days0001493152-24-018908
10-K31 Dec 20231 Apr 202492 days0001493152-24-012141
10-Q30 Sep 202313 Nov 202344 days0001493152-23-040517
10-Q30 Jun 202315 Sep 202377 days0001493152-23-032778

Source: SEC EDGAR company submissions for CIK 0001904286. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.